Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ucommune International (UK) Cash & Equivalents (2018 - 2025)

Ucommune International has reported Cash & Equivalents over the past 8 years, most recently at $5.1 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $5.1 million for Q4 2025, up 45.39% from a year ago — trailing twelve months through Dec 2025 was $5.1 million (up 45.39% YoY), and the annual figure for FY2025 was $13.0 million, up 1137.1%.
  • Cash & Equivalents for Q4 2025 was $5.1 million at Ucommune International, up from $3.5 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for UK hit a ceiling of $7.5 million in Q4 2023 and a floor of $92517.5 in Q4 2022.
  • Median Cash & Equivalents over the past 5 years was $3.5 million (2024), compared with a mean of $3.3 million.
  • Biggest five-year swings in Cash & Equivalents: crashed 99.25% in 2021 and later skyrocketed 8049.72% in 2023.
  • Ucommune International's Cash & Equivalents stood at $200829.9 in 2021, then plummeted by 53.93% to $92517.5 in 2022, then skyrocketed by 8049.72% to $7.5 million in 2023, then tumbled by 53.62% to $3.5 million in 2024, then soared by 45.39% to $5.1 million in 2025.
  • The last three reported values for Cash & Equivalents were $5.1 million (Q4 2025), $3.5 million (Q4 2024), and $7.5 million (Q4 2023) per Business Quant data.